DNA damage response inhibition

Redesigning clinical trials in the era of precision medicine

Genomic-driven clinical studies in breast cancer

Genomic predictors of treatment response in prostate cancer

Synthetic lethality as a basis to select drug combinations

Genomic analysis of childhood tumours; biological and therapeutic implications

Patient-specific peptide vaccines

Proteogenomics in cancer research

Benefits of skin and nipple saving mastectomy

Low dose exemestane usage in breast cancer

BRCA1 and BRCA2 genes and hereditary breast cancers

Stage 4 breast cancer surgery